132 related articles for article (PubMed ID: 3162950)
1. Potentiation of tyramine pressor responses in conscious rats by reversible inhibitors of monoamine oxidase.
Finberg JP; Youdim MB
J Neural Transm Suppl; 1988; 26():11-6. PubMed ID: 3162950
[TBL] [Abstract][Full Text] [Related]
2. [Hypertensive crises with reversible inhibitors of monoamine oxidases? Results of tyramine interaction studies].
Bieck PR
Psychiatr Prax; 1989 Aug; 16 Suppl 1():25-31. PubMed ID: 2587674
[TBL] [Abstract][Full Text] [Related]
3. [The comparative influence of pyrazidol, inkazan and other antidepressant monoamine oxidase inhibitors on the pressor effect of tyramine].
Andreeva NI; Golovina SM; Faermark MF; Shvarts GIa; MashkovskiÄ MD
Farmakol Toksikol; 1991; 54(2):38-40. PubMed ID: 1884793
[TBL] [Abstract][Full Text] [Related]
4. Relationship between tyramine potentiation and monoamine oxidase (MAO) inhibition: comparison between moclobemide and other MAO inhibitors.
Zimmer R
Acta Psychiatr Scand Suppl; 1990; 360():81-3. PubMed ID: 2248084
[TBL] [Abstract][Full Text] [Related]
5. Tyramine pharmacodynamics during combined administration of lazabemide and moclobemide.
Dingemanse J; Hussain Y; Korn A
Int J Clin Pharmacol Ther; 1996 Apr; 34(4):172-7. PubMed ID: 8861736
[TBL] [Abstract][Full Text] [Related]
6. [Comparison of the new MAO-A inhibitors moclobemide, brofaromine and toloxatone with tranylcypromine in an animal experiment: significance for clinical practice].
Da Prada M; Keller HH; Kettler R
Psychiatr Prax; 1989 Aug; 16 Suppl 1():18-24. PubMed ID: 2587673
[TBL] [Abstract][Full Text] [Related]
7. Ranbezolid, a novel oxazolidinone antibacterial: in vivo characterisation of monoamine oxidase inhibitory potential in conscious rats.
Naruganahalli KS; Shirumalla RK; Bansal V; Gupta JB; Das B; Ray A
Eur J Pharmacol; 2006 Sep; 545(2-3):167-72. PubMed ID: 16899241
[TBL] [Abstract][Full Text] [Related]
8. Effect of moclobemide, a new reversible monoamine oxidase inhibitor, on absorption and pressor effect of tyramine.
Korn A; Da Prada M; Raffesberg W; Gasic S; Eichler HG
J Cardiovasc Pharmacol; 1988 Jan; 11(1):17-23. PubMed ID: 2450251
[TBL] [Abstract][Full Text] [Related]
9. Selective pressor enhancement by monoamine oxidase inhibitors in conscious rats.
Kerecsen L; Bunag RD
J Pharmacol Exp Ther; 1989 Nov; 251(2):645-9. PubMed ID: 2509682
[TBL] [Abstract][Full Text] [Related]
10. Enhancement of 5-HT-induced anorexia: a test of the reversibility of monoamine oxidase inhibitors.
Fletcher PJ; Yu PH
Psychopharmacology (Berl); 1989; 98(2):265-8. PubMed ID: 2502797
[TBL] [Abstract][Full Text] [Related]
11. Hypotensive action and weak potentiation of tyramine effect by moclobemide in rats.
Da Prada M; Burkard WP
Acta Psychiatr Scand Suppl; 1990; 360():106-7. PubMed ID: 2248060
[TBL] [Abstract][Full Text] [Related]
12. On the reversibility of reversible MAO inhibitors.
Waldmeier PC
Naunyn Schmiedebergs Arch Pharmacol; 1985 May; 329(3):305-10. PubMed ID: 4022138
[TBL] [Abstract][Full Text] [Related]
13. Effect of oral linezolid on the pressor response to intravenous tyramine.
Cantarini MV; Painter CJ; Gilmore EM; Bolger C; Watkins CL; Hughes AM
Br J Clin Pharmacol; 2004 Nov; 58(5):470-5. PubMed ID: 15521893
[TBL] [Abstract][Full Text] [Related]
14. Pre-clinical pharmacology of moclobemide. A review of published studies.
Burkard WP; Da Prada M; Keller HH; Kettler R; Haefely W
Br J Psychiatry Suppl; 1989 Oct; (6):84-8. PubMed ID: 2695131
[TBL] [Abstract][Full Text] [Related]
15. The advent of a new generation of monoamine oxidase inhibitor antidepressants: pharmacologic studies with moclobemide and brofaromine.
Lavian G; Finberg JP; Youdim MB
Clin Neuropharmacol; 1993; 16 Suppl 2():S1-7. PubMed ID: 8313392
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular sympathomimetic amine interactions in rats treated with monoamine oxidase inhibitors and the novel oxazolidinone antibiotic linezolid.
Humphrey SJ; Curry JT; Turman CN; Stryd RP
J Cardiovasc Pharmacol; 2001 May; 37(5):548-63. PubMed ID: 11336106
[TBL] [Abstract][Full Text] [Related]
17. Limited potentiation of blood pressure response to oral tyramine by brain-selective monoamine oxidase A-B inhibitor, TV-3326 in conscious rabbits.
Weinstock M; Gorodetsky E; Wang RH; Gross A; Weinreb O; Youdim MB
Neuropharmacology; 2002 Nov; 43(6):999-1005. PubMed ID: 12423669
[TBL] [Abstract][Full Text] [Related]
18. Tyramine pressor effect in man: studies with moclobemide, a novel, reversible monoamine oxidase inhibitor.
Korn A; Da Prada M; Raffesberg W; Allen S; Gasic S
J Neural Transm Suppl; 1988; 26():57-71. PubMed ID: 3162952
[TBL] [Abstract][Full Text] [Related]
19. In vivo characterization of T-794, a novel reversible inhibitor of monoamine oxidase-A, as an antidepressant with a wide safety margin.
Kato M; Katayama T; Iwata H; Yamamura M; Matsuoka Y; Narita H
J Pharmacol Exp Ther; 1998 Mar; 284(3):983-90. PubMed ID: 9495858
[TBL] [Abstract][Full Text] [Related]
20. Interaction of moclobemide and tricyclic antidepressants with the tyramine pressor effect in rats.
Burkard W; d'Agostini F; Kettler R; Da Prada M
Psychopharmacology (Berl); 1992; 106 Suppl():S35-6. PubMed ID: 1546137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]